Abstract
Background
The advantages and disadvantages of one-anastomosis gastric bypass (OAGB) with primary modified fundoplication using the excluded stomach (“FundoRing”) is unclear. We aimed to assess the impact of this operation in a randomized controlled trial (RCT) and answer the next questions: (1) What the impact of wrapping the fundus of the excluded part of the stomach in OAGB on protection in the experimental group against developing de novo reflux esophagitis? (2) If preoperative RE could be improved in the experimental group? (3) Can preoperative acid reflux as measured by PH impedance, be treated by the addition of the “FundoRing”?
Methods
The study design was a single-center prospective, interventional, open-label (no masking) RCT (FundoRing Trial) with 1-year follow-up. Endpoints were body mass index (BMI, kg/m2) and acid and bile RE assessed endoscopically by Los Angeles (LA) classification and 24-h pH impedance monitoring. Complications were graded by Clavien-Dindo classification (CDC).
Results
One hundred patients (n = 50 FundoRingOAGB (f-OAGB) vs n = 50 standard OAGB (s-OAGB)) with complete follow-up data were included in the study. During OAGB procedures, patients with hiatal hernia underwent cruroplasty (29/50 f-OAGB; 24/50 s-OAGB). There were no leaks, bleeding, or deaths in either group. At 1 year, BMI in the f-OAGB group was 25.3 ± 2.77 (19–30) vs 26.48 ± 2.8 (21–34) s-OAGB group (p = 0.03). In f-OAGB vs s-OAGB groups, respectively, acid RE was seen in 1 vs 12 patients (p = 0.001) and bile RE in 0 vs 4 patients (p < 0.05).
Conclusion
Routine use of a modified fundoplication of the OAGB-excluded stomach to treat patients with obesity decreased acid and prevented bile reflux esophagitis significantly more effectively than standard OAGB at 1 year in a randomized controlled trial.
Trial Registration
ClinicalTrials.gov Identifier: NCT04834635.
Graphical Abstract
Similar content being viewed by others
Data Availability
The datasets generated or analyzed during the current study are available from the corresponding author upon reasonable request. Requests for data should be directed to the Primary Investigator, Oral Ospanov, bariatric.kz@gmail.com.
References
Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309. https://doi.org/10.1016/S0140-6736(19)30475-1.
Tolone S, Cristiano S, Savarino E, Lucido FS, Fico DI, Docimo L. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2016;12(1):62–9. https://doi.org/10.1016/j.soard.2015.03.011.
Nehmeh WA, Baratte C, Rives-Lange C, Martineau C, Boullenois H, Krivan S, et al. Acid reflux is common in patients with gastroesophageal reflux disease after one-anastomosis gastric bypass. Obes Surg. 2021;31(11):4717–23. https://doi.org/10.1007/s11695-021-05542-3.
Kassir R, Petrucciani N, Debs T, Juglard G, Martini F, Liagre A. Conversion of one anastomosis gastric bypass (OAGB) to Roux-en-Y gastric bypass (RYGB) for biliary reflux resistant to medical treatment: lessons learned from a retrospective series of 2780 consecutive patients undergoing OAGB. Obes Surg. 2020;30(6):2093–8. https://doi.org/10.1007/s11695-020-04460-0.
De Luca M, Piatto G, Merola G, Himpens J, Chevallier JM, Carbajo MA, et al. IFSO updated position statement on one anastomosis gastric bypass (OAGB). Obes Surg. 2021;31(7):3251–78. https://doi.org/10.1007/s11695-021-05413-x.
Keleidari B, Mahmoudieh M, DavarpanahJazi AH, Melali H, Nasr Esfahani F, et al. Comparison of the bile reflux frequency in one anastomosis gastric bypass and Roux-en-Y gastric bypass: a cohort study. Obes Surg. 2019;29:1721–5. https://doi.org/10.1007/s11695-018-03683-6.
Colpaert J, Horevoets J, Maes L, Uijtterhaegen G, Dillemans D. Surgical treatment of therapy-resistant reflux after Roux-en-Y gastric bypass: a case series of the modified Nissen fundoplication. Acta Chir Belg. 2020;120(4):291–6. https://doi.org/10.1080/00015458.2019.1696028.
Ospanov O, Yeleuov G, Fursov A, Yelembayev B, Fursov R, Sergazin Z, Mustafin A. A laparoscopic one anastomosis gastric bypass with wrapping versus nonwrapping fundus of the excluded part of the stomach to treat obese patients (FundoRingOAGB trial): study protocol for a randomized controlled trial. Trials. 2022;23(1):264. https://doi.org/10.1186/s13063-022-06252-6.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1:100–7.
Brasher PM, Brant RF. Sample size calculations in randomized trials: common pitfalls. Can J Anaesth. 2007;54:103–6.
Han MS, Lada MJ, Nieman DR, Tschoner A, Peyre CG, Jones CE, Watson TJ, Peters JH. 24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms. Surg Endosc. 2015;29:1700–8. https://doi.org/10.1007/s00464-014-3867-1.
Ospanov O. The surgical technique of primary modified fundoplication using the excluded stomach with simultaneous gastric bypass. OBES SURG. 2023;33:1311–3. https://doi.org/10.1007/s11695-023-06505-6.
Carbajo MA, Luque-de-León E, Jiménez JM, Ortiz-de-Solórzano J, Pérez-Miranda M, Castro-Alija MJ. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.
Chan DL, Wong SK, Lok HT, Iliopoulos J, Talbot ML, Hennessy A, Ng EK. Accuracy of hiatal hernia diagnosis in bariatric patients: preoperative endoscopy versus intraoperative reference. JGH Open. 2020;4(6):1074–8. https://doi.org/10.1002/jgh3.12388.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–80. https://doi.org/10.1136/gut.45.2.172.
García-García ML, Martín-Lorenzo JG, Lirón-Ruiz R, Torralba-Martínez JA, García-López JA, Aguayo-Albasini JL. Perioperative complications following bariatric surgery according to the Clavien-Dindo classification. Score validation, literature review and results in a single-centre series. Surg Obes Relat Dis. 2017;13(9):1555–61. https://doi.org/10.1016/j.soard.2017.04.018.
Neto RML, Herbella FAM, Schlottmann F, Patti MG. Does DeMeester score still define GERD? Dis Esophagus. 2019;32(5):doy118. https://doi.org/10.1093/dote/doy118.
Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.
De Luca M, Piatto G, Merola G, Himpens J, Chevallier JM, Carbajo MA, et al. IFSO update position statement on one anastomosis gastric bypass (OAGB). Obes Surg. 2021;31(7):3251–78. https://doi.org/10.1007/s11695-021-05413-x.
Poghosyan T, Krivan S, Baratte C. Bile or acid reflux post one-anastomosis gastric bypass: what must we do? Still an unsolved enigma. J Clin Med. 2022;11(12):3346. https://doi.org/10.3390/jcm11123346.
Chen RH, Lautz D, Gilbert RJ, Bueno R. Antireflux operation for gastroesophageal reflux after Roux-en-Y gastric bypass for obesity. Ann Thorac Surg. 2005;80(5):1938–40. https://doi.org/10.1016/j.athoracsur.2004.06.019.
Liakakos T, Karamanolis G, Patapis P, Misiakos EP. Gastroesophageal reflux disease: medical or surgical treatment? Gastroenterol Res Pract. 2009;2009:371580. https://doi.org/10.1155/2009/371580.
Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C. Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc. 2006;20:159–65.
Dallemagne B, Perretta S. Twenty years of laparoscopic fundoplication for GERD. World J Surg. 2011;35:1428–35.
Mardani J, Lundell L, Engström C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg. 2011;253:875–8.
Soprani A, Carandina S, El Kareh I, Genser L, Cady J. Revision of lap-band to MGB. In: Deitel M. (eds) Essentials of mini ‒ one anastomosis gastric bypass. Springer, Cham. 2018: https://doi.org/10.1007/978-3-319-76177-0_22.
Ospanov OB. The gastric bypass and fundoplication in bariatric surgery: the comments on published papers and our classification of combination procedures. Obes Surg. 2021;31:4643–4. https://doi.org/10.1007/s11695-021-05505-8.
Sheikh L, Pearless LA, Booth MW. Laparoscopic silastic ring mini-gastric bypass (SR-MGBP): up to 11 year results from a single centre. Obes Surg. 2017;27(9):2229–34. https://doi.org/10.1007/s11695-017-2659-9.
Cazzo E, Jimenez LS, Valerini FG, de Freitas Diniz TB, Ramos AC, Chaim EA. Weight loss and vomiting 1 year after banded versus non-banded one anastomosis gastric bypass: a prospective randomized trial. Obes Surg. 2020;30(5):1719–25. https://doi.org/10.1007/s11695-020-04393-8.
Miller KA, Radauer M, Buchwald JN, McGlennon TW, Ardelt-Gattinger E. 5-year results of banded one-anastomosis gastric bypass: a pilot study in super-obese patients. Obes Surg. 2020;30(11):4307–14.
Kral J, Selucka J, Dolecek F, Waloszkova K, Buzga M, Spicak J, Machytka E. Endoscopic extraction of migrated gastric bypass Fobi ring in patient after gastric bypass. Endoscopy. 2022;54(S 02):E1030–1. https://doi.org/10.1055/a-1903-1450.
Ospanov O, Nadirov K, Koikov V, Zharov N. One anastomosis gastric bypass with fundoplication of remnant stomach for weight regain prevention: case report. Int J Surg Case Rep. 2022;20(97):107431. https://doi.org/10.1016/j.ijscr.2022.107431.
Acknowledgements
The authors thank all of the support personnel of the Department of Surgical Disease and Bariatric Surgery, Astana Medical University, Hospital “Green Clinic” and Surgery Center of Professor Oral Ospanov, Astana, Kazakhstan, for their hard work and dedication.
Funding
The work was supported by The Society of Bariatric and Metabolic Surgeons of Kazakhstan, Astana, Kazakhstan, Grant #2021/1. The funder had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.
Author information
Authors and Affiliations
Contributions
O. O. was the principal investigator; he conceived the study. N. Z. contributed to the study design and to the development of the proposal. G. Y. led the trial methodologists. B. Y. and K. S. were involved in patient recruitment and acquisition of data. J. B. was involved in review of the scientific literature, critical substantive revision, and the post-submission revision of the manuscript. All authors approved the final version of the manuscript to be submitted.
Corresponding author
Ethics declarations
Informed Consent
Informed consent was obtained from all participants.
Ethics Approval
The study was conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments and with the approval of the regional ethics committee of Astana, Kazakhstan. The study protocol, patients’ information sheets, and informed consent forms were approved by the local ethics committee (Research Ethics Committee/Institutional Review Board [REC/IRB]): Ethics committee of SBMSK approved the trial on 29.03.2021, Approval Number: #1.
Conflict of Interest
J. N. Buchwald received a small grant for writing. All other authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Modified fundoplication of the OAGB used excluded stomach treats obesity and reflux esophagitis.
• Wrapping fundus of the excluded stomach in OAGB protected developing de novo reflux esophagitis.
• Primary fundoplication of the OAGB used excluded stomach prevented bile reflux esophagitis.
• Primary FundoRingOAGB used excluded stomach should be used routinely in each case of OAGB.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ospanov, O., Yeleuov, G., Buchwald, J.N. et al. A Randomized Controlled Trial of Acid and Bile Reflux Esophagitis Prevention by Modified Fundoplication of the Excluded Stomach in One-Anastomosis Gastric Bypass: 1-Year Results of the FundoRing Trial. OBES SURG 33, 1974–1983 (2023). https://doi.org/10.1007/s11695-023-06618-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06618-y